Respiratory adverse effects of IBD treatments: mechanisms, manifestations, and management strategies
Canadian Journal of Physiology and Pharmacology · 2026
DOI: 10.1139/cjpp-2026-0151 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2026. Verfasst von Maha E Alsadik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal and Forensic Medicine, Faculty of Medicine, Mutah University, Al-Karak, Jordan. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Lung Diseases, Immunomodulating Agents. Die Arbeit nennt 59 Literaturangaben.
Abstract (Originalsprache)
Increasing use of immunomodulators and biologics in inflammatory bowel disease (IBD) has expanded the spectrum of pulmonary complications. This review aimed to summarize mechanisms, clinical features, and management of drug-induced pulmonary toxicity in IBD. A narrative review of the PubMed/MEDLINE, Scopus, Embase, and Cochrane Library databases was conducted for studies published between January 2000 and July 2026, using combinations of terms related to inflammatory bowel disease, individual drug classes, and pulmonary toxicity; original studies, systematic reviews, meta-analyses, and case series/reports meeting predefined inclusion criteria were selected by two authors. Each drug class exhibits a characteristic pulmonary toxicity profile, requiring distinct diagnostic and therapeutic approaches. Clinicians must maintain high suspicion for pulmonary toxicity to ensure timely intervention and improved patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal and Forensic Medicine, Faculty of Medicine, Mutah University, Al-Karak, Jordan.
- Department of Dental and Medical Sciences, Faculty of Dentistry, Mutah University, Al-Karak, Jordan.
ORCID-Profile: Khaled A Abdel-Sater
Zitieren
APA
Alsadik, M., Abdelmoaty, A., & Abdel-Sater, K. (2026). Respiratory adverse effects of IBD treatments: mechanisms, manifestations, and management strategies. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2026-0151
Vancouver
Alsadik M, Abdelmoaty A, Abdel-Sater K. Respiratory adverse effects of IBD treatments: mechanisms, manifestations, and management strategies. Canadian Journal of Physiology and Pharmacology. 2026. doi:10.1139/cjpp-2026-0151
BibTeX
@article{Alsadik2026,
author = {Alsadik, Maha E and Abdelmoaty, Ahmed A and Abdel-Sater, Khaled A},
title = {Respiratory adverse effects of IBD treatments: mechanisms, manifestations, and management strategies},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2026},
doi = {10.1139/cjpp-2026-0151}
}
EUVIMED